Plain-English translation of NCT05646576 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a specialized supportive care program — called PEACE — can help improve quality of life and reduce side effects for people receiving adoptive cell therapy (a type of personalized cell-based treatment) for blood cancers like lymphoma, leukemia, and multiple myeloma. Half of participants will receive this additional supportive care alongside their regular cancer treatment, while the other half will receive standard cancer care alone.
Cell therapy can be intense and difficult for patients to endure. Researchers want to learn whether adding specialized supportive care — focused on managing symptoms, side effects, and emotional wellbeing — can make this treatment journey easier and improve overall quality of life.
You likely qualify if…
You likely don't qualify if…
If you join, you'll either receive the new supportive care program (PEACE) or standard care. If assigned to PEACE, you'll meet with a supportive care specialist within one week of starting treatment and at least twice weekly while hospitalized. The specialist will continue to support you for up to one year. Everyone in the study will complete brief surveys about their quality of life and wellbeing on specific dates. The entire study lasts up to 2 years.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States